Brian J Caveney's most recent trade in Laboratory Corp. Of America Holdings was a trade of 2,000 Common Stock done at an average price of $247 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Sale of securities on an exchange or to another person at price $ 247.00 per share. | 03 Jun 2025 | 2,000 | 30,066 (0%) | 0% | 247 | 494,000 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 4,840 | 34,175 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.67 per share. | 27 Mar 2025 | 2,109 | 32,066 (0%) | 0% | 231.7 | 488,592 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 6,700 | 6,700 | - | - | Non-qualified Stock Options | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 2,220 | 4,661 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 473 | 4,188 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 473 | 29,471 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 136 | 29,335 (0%) | 0% | 245.1 | 33,339 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 670 | 28,763 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 670 | 3,070 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 517 | 2,553 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 517 | 29,068 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 212 | 28,551 (0%) | 0% | 247.7 | 52,521 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 149 | 28,919 (0%) | 0% | 246.3 | 36,694 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 112 | 29,031 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 112 | 2,441 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 33 | 28,998 (0%) | 0% | 246.3 | 8,127 | Common Stock |
| Labcorp | Brian Caveney J. | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 472 | 21,523 (0%) | 0% | - | Common Stock | |
| Labcorp | J. Caveney Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 472 | 15,296 | - | - | Restricted Stock Unit | |
| Labcorp | J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 137 | 21,386 (0%) | 0% | 227.5 | 31,161 | Common Stock |
| Labcorp | J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 6,200 | 6,200 | - | - | Non-qualified Stock Options | |
| Labcorp | Caveney Brian J. | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 2,010 | 16,397 | - | - | Restricted Stock Unit | |
| Labcorp | J. Caveney Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 517 | 15,880 | - | - | Restricted Stock Unit | |
| Labcorp | J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 517 | 21,143 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian Caveney J. | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 171 | 20,972 (0%) | 0% | 223.7 | 38,254 | Common Stock |
| Labcorp | Caveney Brian J. | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 112 | 15,768 | - | - | Restricted Stock Unit | |
| Labcorp | Caveney J. Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 112 | 21,084 (0%) | 0% | - | Common Stock | |
| Labcorp | Caveney J. Brian | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.70 per share. | 06 Feb 2024 | 33 | 21,051 (0%) | 0% | 223.7 | 7,382 | Common Stock |
| Labcorp | J. Caveney Brian | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 495 | 14,387 | - | - | Restricted Stock Unit | |
| Labcorp | Brian Caveney J. | EVP, Pres of ED, CMO & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 495 | 20,792 (0%) | 0% | - | Common Stock | |
| Labcorp | J. Brian Caveney | EVP, Pres of ED, CMO & CSO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 166 | 20,626 (0%) | 0% | 221.5 | 36,776 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 11,648 | 14,629 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 1,000 | 1,000 | - | - | Non-qualified Stock Options | |
| Labcorp | Brian J. Caveney | EVP, Pres of ED, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 300 | 2,981 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 6,763 | 23,175 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 2,990 | 20,185 (0%) | 0% | 224.7 | 671,853 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 423 | 2,681 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 423 | 16,536 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 124 | 16,412 (0%) | 0% | 248.1 | 30,768 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 4,400 | 4,400 | - | - | Non-qualified Stock Options | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 1,390 | 3,104 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 560 | 1,714 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 560 | 16,277 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.50 per share. | 04 Feb 2023 | 164 | 16,113 (0%) | 0% | 244.5 | 40,098 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 443 | 2,274 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 443 | 15,861 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.99 per share. | 02 Feb 2023 | 144 | 15,717 (0%) | 0% | 255.0 | 36,719 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2022 | 2,010 | 16,291 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2022 | 2,010 | 2,717 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 233.77 per share. | 05 Nov 2022 | 894 | 15,397 (0%) | 0% | 233.8 | 208,990 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Purchase of securities on an exchange or from another person at price $ 232.98 per share. | 07 Sep 2022 | 44 | 14,281 (0%) | 0% | 233.0 | 10,251 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Purchase of securities on an exchange or from another person at price $ 242.24 per share. | 07 Jun 2022 | 42 | 14,171 (0%) | 0% | 242.2 | 10,174 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2022 | 4,241 | 16,012 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.42 per share. | 27 Mar 2022 | 1,883 | 14,129 (0%) | 0% | 276.4 | 520,499 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 4,500 | 4,500 | - | - | Non-qualified Stock Options | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,354 | 12,549 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,354 | 4,727 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 1,270 | 7,365 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.68 per share. | 11 Feb 2022 | 694 | 11,771 (0%) | 0% | 272.7 | 189,240 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 284 | 10,195 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 284 | 7,081 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.68 per share. | 11 Feb 2022 | 84 | 12,465 (0%) | 0% | 272.7 | 22,905 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 560 | 10,076 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 560 | 6,095 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.48 per share. | 04 Feb 2022 | 165 | 9,911 (0%) | 0% | 277.5 | 45,784 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 443 | 9,663 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 443 | 6,655 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.18 per share. | 02 Feb 2022 | 147 | 9,516 (0%) | 0% | 273.2 | 40,157 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 2,010 | 7,098 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2021 | 2,010 | 10,080 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 274.84 per share. | 05 Nov 2021 | 899 | 9,181 (0%) | 0% | 274.8 | 247,081 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2021 | 2,413 | 9,080 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 251.58 per share. | 27 Mar 2021 | 1,079 | 8,001 (0%) | 0% | 251.6 | 271,455 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,353 | 9,108 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 2,353 | 7,366 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 699 | 6,667 (0%) | 0% | 238.3 | 166,544 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 283 | 5,098 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 283 | 11,461 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 234 | 4,885 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 234 | 11,744 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 85 | 5,013 (0%) | 0% | 238.3 | 20,252 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 70 | 4,815 (0%) | 0% | 238.3 | 16,678 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 560 | 11,978 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 560 | 4,841 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.78 per share. | 04 Feb 2021 | 190 | 4,651 (0%) | 0% | 223.8 | 42,518 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 4,600 | 4,600 | - | - | Non-qualified Stock Options | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 1,330 | 12,538 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 2,010 | 5,107 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 2,010 | 11,208 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.42 per share. | 05 Nov 2020 | 886 | 4,221 (0%) | 0% | 214.4 | 189,976 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 970 | 3,386 (0%) | 0% | - | Common Stock | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Sep 2020 | 970 | 13,218 | - | - | Restricted Stock Unit | |
| Labcorp | Brian J. Caveney | EVP, President of Diagnostics | Payment of exercise price or tax liability using portion of securities received from the company at price $ 180.99 per share. | 25 Sep 2020 | 289 | 3,097 (0%) | 0% | 181.0 | 52,306 | Common Stock |